INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 138 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,000 | -86.7% | 994 | -91.1% | 0.00% | – |
| Q3 2017 | $15,000 | -63.4% | 11,161 | -57.7% | 0.00% | – |
| Q2 2017 | $41,000 | -51.8% | 26,396 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $85,000 | +150.0% | 26,396 | +5.9% | 0.00% | – |
| Q4 2016 | $34,000 | +88.9% | 24,920 | +115.0% | 0.00% | – |
| Q3 2016 | $18,000 | -69.5% | 11,591 | +3.5% | 0.00% | -100.0% |
| Q1 2016 | $59,000 | -57.2% | 11,194 | -11.4% | 0.00% | 0.0% |
| Q2 2015 | $138,000 | – | 12,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |